IP Library Granted Patent US 7,417,118
Granted Patent B2
US 7,417,118 · App. 10/819,352 · Granted Aug 26, 2008

Pharmaceutical composition containing artificial oxygen carrier

Assignee: Nipro Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,417,118
App. No.
10/819,352
Granted
Aug 26, 2008
Kind
B2
Abstract

A pharmaceutical composition containing an artificial oxygen carrier, which has high oxygen carrying efficiency; and has a required colloid osmotic pressure, an appropriate crystalloid osmotic pressure, pH, and electrolyte balance. The composition is prepared by appropriately adding at least one substance selected from the group consisting of a compound capable of providing a colloid osmotic pressure, an electrolyte, a saccharide, an amino acid, an antioxidant, a pH adjuster, and an isotonizing agent to a preparation including a liposome-encapsulated hemoglobin in which a hemoglobin is encapsulated in a liposome or to a preparation including a conjugate of a porphyrin-iron complex and albumin.

Claims (7)

1. A pharmaceutical composition characterized by comprising a liposome-encapsulated hemoglobin capable of adsorbing and desorbing oxygen reversibly in a living body and albumin located on the liposome-encapsulated hemoglobin in a concentration to provide a colloid osmotic pressure of about 1 to 50 mmHg,

wherein the liposome contains a conjugate of a lipid and a polyalkylene glycol and

further wherein the composition is a liquid having said colloid osmotic pressure of about 1 to 50 mmHg, a crystalloid osmotic pressure of about 50 to 500 mOsm, P50 of about 1 to 50 Torr, and a pH of about 5.6 to 8.0.

2. The pharmaceutical composition according to claim 1 , wherein the liposome contains a conjugate of a non-phospholipid lipid and a polyalkylene glycol.

3. The pharmaceutical composition according to claim 1 , wherein the hemoglobin is a recombinant hemoglobin.

4. A blood infusion comprising the pharmaceutical composition according to claim 1 .

5. An organ storage perfusion solution, an extra corporeal circulation solution, or a cell culture solution comprising the pharmaceutical composition according to claim 1 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 19, 2004
From: KAI, TOSHIYA; KATAYAMA, NAOHISA; AZUMA, YUKO; YOKOE, JUNICHI; KIDA, YOSHINORI; HUKUTOMI, IPPEI; SATO, MAKOTO; TSUCHIDA, EISHUN; TAKEOKA, SHINJI; KOMATSU, TERUYUKI; SAKAI, HIROMI; SO, KEITARO
To: NIPRO CORPORATION
Reel/Frame 015715/0116 →
Priority Claims (1)
JP 2003-103875 · Apr 8, 2003 · national
Continuity (1)
Related Publication 20040258745A1 · Dec 23, 2004